| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.27 | 2e-14 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.22 | 4e-10 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.2 | 4e-09 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-08 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-08 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.19 | 6e-08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.19 | 7e-08 |